Mimedx Group, Inc. splits its revenue into 5 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Surgical at $40.0 million, 64% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
304
|
62
|
64
|
59
|
118
|
114
|
99
|
88
|
93
|
| Hospital Site Of Service |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
50
share 54.1%
|
| Surgical |
155
+15.3%
share 51.0%
|
40
+9.1%
share 64.2%
|
39
+15.1%
share 61.1%
|
36
+13.2%
share 61.7%
|
39
+24.9%
share 33.4%
|
37
share 32.2%
|
34
share 34.6%
|
32
share 36.4%
|
32
share 34.0%
|
| Private Office Site Of Service |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
30
share 31.8%
|
| Wound |
149
-42.6%
share 49.0%
|
22
-71.0%
share 35.8%
|
25
-61.1%
share 38.9%
|
23
-59.7%
share 38.3%
|
79
+28.2%
share 66.6%
|
77
share 67.8%
|
64
share 65.4%
|
56
share 63.6%
|
61
share 66.0%
|
| Other Site Of Service |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
13
share 14.1%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDXG (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Marietta, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1376339
- Former names
- Alynx, Co. (until Apr 2, 2008)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.